Search
Exact matches only
Search in title
Search in content
Search in comments
Search in excerpt
Search in posts
Search in pages
Search in groups
Search in users
Search in forums
Filter by Custom Post Type
Filter by Categories
Filter by Report Categories
Advance Interior Materials
Agriculture Industry
Agrochemicals & fertilizers
Animal feed and feed additives
Automotive Sector
Automotive & Transportation
Biotechnology
Building & Construction
Building & Construction Materials
Electronics & Semiconductors
Electronic Devices
Electronic Security
Energy & Resources
Alternative Energy
Distribution & Utilities
Power generation and storage
Food & Beverage
Food Additives and Nutricosmetics
Life Sciences
Healthcare
Wellness
Personal Care & Cosmetics
Materials & Chemicals
Advanced Materials
Advanced Materials (Green Building Materials)
Ceramic & Fiber
Coatings & printing inks
Organic Chemicals
Paints
Petrochemicals
Plastics
Polymers & Resins
Renewable Chemicals
Specialty & Fine Chemicals
Specialty glass
Specialty Polymer
Medical Devices
Pharmaceuticals
Clinic Diagnostics
Technology & Media
Communication Infrastructure
Communication Services
HVAC and Construction
Next Generation Technologies
Textiles
Smart Textiles
{ "homeurl": "https://www.marketresearchandstatistics.com/", "resultstype": "vertical", "resultsposition": "hover", "itemscount": 4, "imagewidth": 70, "imageheight": 70, "resultitemheight": "auto", "showauthor": 0, "showdate": 0, "showdescription": 1, "charcount": 3, "noresultstext": "No results!", "didyoumeantext": "Did you mean:", "defaultImage": "https://www.marketresearchandstatistics.com/wp-content/plugins/ajax-search-pro/img/default.jpg", "highlight": 0, "highlightwholewords": 1, "openToBlank": 0, "scrollToResults": 0, "resultareaclickable": 1, "autocomplete": { "enabled": 1, "googleOnly": 0, "lang": "en" }, "triggerontype": 1, "triggeronclick": 1, "triggeronreturn": 1, "triggerOnFacetChange": 0, "overridewpdefault": 0, "redirectonclick": 1, "redirectClickTo": "results_page", "redirect_on_enter": 1, "redirectEnterTo": "results_page", "redirect_url": "?s={phrase}", "more_redirect_url": "?s={phrase}", "settingsimagepos": "left", "settingsVisible": 0, "hresulthidedesc": "0", "prescontainerheight": "400px", "pshowsubtitle": "0", "pshowdesc": "1", "closeOnDocClick": 1, "iifNoImage": "description", "iiRows": 2, "iiGutter": 5, "iitemsWidth": 200, "iitemsHeight": 200, "iishowOverlay": 1, "iiblurOverlay": 1, "iihideContent": 1, "loaderLocation": "auto", "analytics": 0, "analyticsString": "", "aapl": { "on_click": 0, "on_magnifier": 0, "on_enter": 0, "on_typing": 0 }, "compact": { "enabled": 0, "width": "100%", "closeOnMagnifier": 1, "closeOnDocument": 0, "position": "static", "overlay": 0 }, "animations": { "pc": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "fadeInDown" }, "mob": { "settings": { "anim" : "fadedrop", "dur" : 300 }, "results" : { "anim" : "fadedrop", "dur" : 300 }, "items" : "voidanim" } }, "autop": { "state": "disabled", "phrase": "", "count": 10 } }

LAMEA Molecular Diagnostics Market

$1500

The LAMEA Molecular Diagnostics market is segmented based on components, end user, and geography. The components segment is further sub-segmented into hardware and software.

Publisher’s Note: Reports from KBV Research comes with a powerful Market Research & Analytics tool which facilitates the client to see data graphically. Request a free demo of the Market Research & Analytics Tool here.
Report DescriptionResearch ScopeTable of ContentPricing

LAMEA Molecular Diagnostics Market Overview

Molecular Diagnostics is used to identify or monitor biomarkers associated with any particular diseases or conditions. This test could also help in detecting and quantifying the presence of specific bacteria and viruses. These devices help surgeons in deciding that which therapy would work best on different patients. Molecular Diagnostics detect the diseases by analyzing RNA (Ribonucleic Acid) or DNA (Deoxyribonucleic Acid) in humans. These diagnostics are mainly used for clinical testing devices that are supplied in clinics, hospitals, laboratories, and research institutes.

Rise in the incidence of chronic & infectious diseases and technological advancements is leading the market for molecular diagnostics market in LAMEA. According to the report by Avert in 2016, In Latin America, 1.6 people and In Brazil 830,000 peoples are dealing with HIV. Considering Middle East, studies stated that Middle East is a region with highest number of breast cancer cases and diseases. And the most effected population is the women under 60. In Addition, doctors have also stated the people are still unaware about the health issues in U.A.E and it is leading towards increase in infectious diseases.

LAMEA Molecular Diagnostics Market Segmentation

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

The Molecular Diagnostics Market is segmented on the basis of Product & Services, Technology, Application, End-user and Region. Based on Product & Services, the market is segmented into instruments, reagents & Kits, and software & services. Reagents & Kits is expected to gather largest share in the market due to rising demand of reagents in clinical centers and diagnostics centers. Based on Technology, market is segmented into Polymerase Chain Reaction (PCR), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Hybridization, Microarray, DNA Sequencing and Next-Generation Sequencing.

Based on Application, the market is segmented into six types such as Infectious diseases molecular testing, Molecular oncology testing, Inherited diseases molecular testing, Identity testing, Tissue type testing and Pharmacogenetics testing. Infectious Diseases includes Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG), Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hepatitis B, Hepatitis C, Tuberculosis (TB), Methicillin-Resistant Staphylococcus Aureus (MRSA) and other infectious diseases. On the other hand, oncology is further divided into Breast Cancer, Prostate Cancer, Colorectal Cancer and others. The infectious diseases molecular testing is mostly preferred in the hospitals and clinical centers.  Based on End-User, the market is segmented into i clinics, hospitals, laboratories, and research institutes. Based on Country, market is segmented into Brazil, Argentina, UAE, Saudia Arabia, South Africa, Nigeria and Rest of LAMEA.

 LAMEA Molecular Diagnostics Market Key Companies

The report covers the analysis of key stake holders of the Molecular Diagnostics market. Key companies profiled in the report includeAbbott Laboratories,Qiagen N.V,Roche Diagnostics,Grifols,Siemens Healthcare (Siemens AG),Becton Dickinson and Company and Danaher Corporation.

LAMEA Molecular Diagnostics Market Segmentation

Market Segmentation:

By Product & Services

  • Reagents & Kits
  • Instruments
  • Software& Services

By Technology

  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Technology
  • Hybridization
  • DNA Sequencing & Next-Generation Sequencing
  • Microarray
  • Other Technologies

By Application

  • Infectious Diseases
    • Chlamydia Trachomatis & Neisseria Gonorrhoea
    • Hepatitis B & Hepatitis C
    • Human Papillomavirus
    • Human Immunodeficiency Virus
    • Tuberculosis
    • Methicillin-Resistant Staphylococcus Aurous
    • Others
  • Oncology
    • Breast Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Other Cancers
  • Blood Screening
  • Genetic Tests
  • Microbiology
  • Other Applications

By End User

  • Hospital & Academic Laboratories
  • Reference Laboratories
  • Other End Users

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Company Profiled

  • Abbott Laboratories
  • Qiagen N.V
  • Roche Diagnostics
  • Grifols
  • Siemens Healthcare (Siemens AG)
  • Becton Dickinson and Company
  • Danaher Corporation

Unique Offerings from KBV Research

  • Exhaustive coverage of LAMEAMolecular Diagnostics Market
  • Highest number of market tables
  • Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
  • Subscription based model available
  • Free of cost quarterly updates
  • Free of cost automatic pdf report generation
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Chapter 1.  Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  LAMEA Molecular Diagnostics Market, by Product & Services

1.4.2  LAMEA Molecular Diagnostics Market, by Technology

1.4.3  LAMEA Molecular Diagnostics Market, by Application

1.4.4  LAMEA Molecular Diagnostics Market, by End User

1.4.5  LAMEA Molecular Diagnostics Market, by Country

1.5  Methodology for the research

Chapter 2.  Executive Summary

Chapter 3.  Market Overview

3.1  Introduction

3.2  Drivers, Restraints and Opportunities

3.2.1  Market Drivers

3.2.2  Market Restraints

Chapter 4.  LAMEA Molecular Diagnostics Market

4.1  LAMEA Molecular Diagnostics Market by Product & Services

4.1.1  LAMEA Molecular Diagnostics Reagents & Kits Market by Country

4.1.2  LAMEA Molecular Diagnostics Instruments Market by Country

4.1.3  LAMEA Molecular Diagnostics Software & Services Market by Country

Chapter 5.  LAMEA Molecular Diagnostics Market by Technology

5.1  Introduction

5.1.1  LAMEA Polymerase Chain Reaction Molecular Diagnostics Market by Country

5.1.2  LAMEA Isothermal Nucleic Acid Amplification Technology Molecular Diagnostics Market by Country

5.1.3  LAMEA Hybridization Molecular Diagnostics Market by Country

5.1.4  LAMEA DNA Sequencing & Next-Generation Sequencing Molecular Diagnostics Market by Country

5.1.5  LAMEA Microarray Molecular Diagnostics Market by Country

5.1.6  LAMEA Other Technologies Market by Country

Chapter 6.  LAMEA Molecular Diagnostics Market by Application

6.1  Introduction

6.1.1  LAMEA Infectious Diseases Molecular Diagnostics Market by Country

6.1.2  LAMEA Infectious Diseases Molecular Diagnostics Market by Type

6.1.2.1  LAMEA Chlamydia Trachomatis & Neisseria Gonorrhea Molecular Diagnostics Market by Country

6.1.2.2  LAMEA Hepatitis B & Hepatitis C Molecular Diagnostics Market by Country

6.1.2.3  LAMEA Human Papillomavirus Molecular Diagnostics Market by Country

6.1.2.4  LAMEA Human Immunodeficiency Virus Molecular Diagnostics Market by Country

6.1.2.5  LAMEA Tuberculosis Molecular Diagnostics Market by Country

6.1.2.6  LAMEA Methicillin-Resistant Staphylococcus Aurous Molecular Diagnostics Market by Country

6.1.2.7  LAMEA Molecular Diagnostics in Other Infectious Diseases Market by Country

6.1.3  LAMEA Oncology Molecular Diagnostics Market by Country

6.1.4  LAMEA Oncology Molecular Diagnostics Market by Type

6.1.4.1  LAMEA Breast Cancer Molecular Diagnostics Market by Country

6.1.4.2  LAMEA Colorectal Cancer Molecular Diagnostics Market by Country

6.1.4.3  LAMEA Prostate Cancer Molecular Diagnostics Market by Country

6.1.4.4  LAMEA Other Cancers Molecular Diagnostics Market by Country

6.1.5  LAMEA Blood Screening Molecular Diagnostics Market by Country

6.1.6  LAMEA Genetic Tests Molecular Diagnostics Market by Country

6.1.7  LAMEA Microbiology Molecular Diagnostics Market by Country

6.1.8  LAMEA Other Applications Market by Country

Chapter 7.  LAMEA Molecular Diagnostics Market by End User

7.1  Introduction

7.1.1  LAMEA Molecular Diagnostics Market for Hospital & Academic Laboratories by Country

7.1.2  LAMEA Molecular Diagnostics Market for Reference Laboratories by Country

7.1.3  LAMEA Molecular Diagnostics Market for Other End Users by Country

Chapter 8.  LAMEA Molecular Diagnostics Market by Country

8.1  Introduction

8.2  Brazil Molecular Diagnostics Market

8.2.1  Brazil Molecular Diagnostics Market by Product & Services

8.2.2  Brazil Molecular Diagnostics Market by Technology

8.2.3  Brazil Molecular Diagnostics Market by Application

8.2.3.1  Brazil Infectious Diseases Molecular Diagnostics Market by Type

8.2.3.2  Brazil Oncology Molecular Diagnostics Market by Type

8.2.4  Brazil Molecular Diagnostics Market by End User

8.3  Argentina Molecular Diagnostics Market

8.3.1  Argentina Molecular Diagnostics Market by Product & Services

8.3.2  Argentina Molecular Diagnostics Market by Technology

8.3.3  Argentina Molecular Diagnostics Market by Application

8.3.3.1  Argentina Infectious Diseases Molecular Diagnostics Market by Type

8.3.3.2  Argentina Oncology Molecular Diagnostics Market by Type

8.3.4  Argentina Molecular Diagnostics Market by End User

8.4  UAE Molecular Diagnostics Market

8.4.1  UAE Molecular Diagnostics Market by Product & Services

8.4.2  UAE Molecular Diagnostics Market by Technology

8.4.3  UAE Molecular Diagnostics Market by Application

8.4.3.1  UAE Infectious Diseases Molecular Diagnostics Market by Type

8.4.3.2  UAE Oncology Molecular Diagnostics Market by Type

8.4.4  UAE Molecular Diagnostics Market by End User

8.5  Saudi Arabia Molecular Diagnostics Market

8.5.1  Saudi Arabia Molecular Diagnostics Market by Product & Services

8.5.2  Saudi Arabia Molecular Diagnostics Market by Technology

8.5.3  Saudi Arabia Molecular Diagnostics Market by Application

8.5.3.1  Saudi Arabia Infectious Diseases Molecular Diagnostics Market by Type

8.5.3.2  Saudi Arabia Oncology Molecular Diagnostics Market by Type

8.5.4  Saudi Arabia Molecular Diagnostics Market by End User

8.6  South Africa Molecular Diagnostics Market

8.6.1  South Africa Molecular Diagnostics Market by Product & Services

8.6.2  South Africa Molecular Diagnostics Market by Technology

8.6.3  South Africa Molecular Diagnostics Market by Application

8.6.3.1  South Africa Infectious Diseases Molecular Diagnostics Market by Type

8.6.3.2  South Africa Oncology Molecular Diagnostics Market by Type

8.6.4  South Africa Molecular Diagnostics Market by End User

8.7  Nigeria Molecular Diagnostics Market

8.7.1  Nigeria Molecular Diagnostics Market by Product & Services

8.7.2  Nigeria Molecular Diagnostics Market by Technology

8.7.3  Nigeria Molecular Diagnostics Market by Application

8.7.3.1  Nigeria Infectious Diseases Molecular Diagnostics Market by Type

8.7.3.2  Nigeria Oncology Molecular Diagnostics Market by Type

8.7.4  Nigeria Molecular Diagnostics Market by End User

8.8  Rest of LAMEA Molecular Diagnostics Market

8.8.1  Rest of LAMEA Molecular Diagnostics Market by Product & Services

8.8.2  Rest of LAMEA Molecular Diagnostics Market by Technology

8.8.3  Rest of LAMEA Molecular Diagnostics Market by Application

8.8.3.1  Rest of LAMEA Infectious Diseases Molecular Diagnostics Market by Type

8.8.3.2  Rest of LAMEA Oncology Molecular Diagnostics Market by Type

8.8.3.3  Rest of LAMEA Molecular Diagnostics Market by End User

Chapter 9.  Company Profiles

9.1  Abbott Laboratories

9.1.1  Company Overview

9.1.2  Financial Analysis

9.1.3  Segmental and Regional Analysis

9.1.4  Research & Development Expense

9.2  Qiagen N.V.

9.2.1  Company Overview

9.2.2  Financial Analysis

9.2.3  Segmental and Regional Analysis

9.2.4  Research & Development Expense

9.3  Roche Diagnostics

9.3.1  Company Overview

9.3.2  Financial Analysis

9.3.3  Segmental and Regional Analysis

9.3.4  Research & Development Expense

9.4  Grifols

9.4.1  Company Overview

9.4.2  Financial Analysis

9.4.3  Segmental and Regional Analysis

9.5  Siemens Healthcare (Siemens AG)

9.5.1  Company Overview

9.5.2  Financial Analysis

9.5.3  Segmental and Regional Analysis

9.5.4  Research & Development Expense

9.6  Becton Dickinson and Company

9.6.1  Company Overview

9.6.2  Financial Analysis

9.6.3  Segmental and Regional Analysis

9.6.4  Research & Development Expense

9.7  Danaher Corporation

9.7.1  Company Overview

9.7.2  Financial Analysis

9.7.3  Segmental and Regional Analysis

9.7.4  Research & Development Expense

LIST OF TABLES

TABLE 1  LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 2  LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 3  LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 4  LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 5  LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 6  LAMEA MOLECULAR DIAGNOSTICS REAGENTS & KITS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 7  LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 8  LAMEA MOLECULAR DIAGNOSTICS INSTRUMENTS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 9  LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 10  LAMEA MOLECULAR DIAGNOSTICS SOFTWARE & SERVICES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 11  LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 12  LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 13  LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 14  LAMEA POLYMERASE CHAIN REACTION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 15  LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 16  LAMEA ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 17  LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 18  LAMEA HYBRIDIZATION MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 19  LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 20  LAMEA DNA SEQUENCING & NEXT-GENERATION SEQUENCING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 21  LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 22  LAMEA MICROARRAY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 23  LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 24  LAMEA OTHER TECHNOLOGIES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 25  LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 26  LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 27  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 28  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 29  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 30  LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 31  LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 32  LAMEA CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 33  LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 34  LAMEA HEPATITIS B & HEPATITIS C MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 35  LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 36  LAMEA HUMAN PAPILLOMAVIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 37  LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 38  LAMEA HUMAN IMMUNODEFICIENCY VIRUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 39  LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 40  LAMEA TUBERCULOSIS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 41  LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 42  LAMEA METHICILLIN-RESISTANT STAPHYLOCOCCUS AUROUS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 43  LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 44  LAMEA MOLECULAR DIAGNOSTICS IN OTHER INFECTIOUS DISEASES MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 45  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 46  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 47  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 48  LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 49  LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 50  LAMEA BREAST CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 51  LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 52  LAMEA COLORECTAL CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 53  LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 54  LAMEA PROSTATE CANCER MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 55  LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 56  LAMEA OTHER CANCERS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 57  LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 58  LAMEA BLOOD SCREENING MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 59  LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 60  LAMEA GENETIC TESTS MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 61  LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 62  LAMEA MICROBIOLOGY MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 63  LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 64  LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 65  LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 66  LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 67  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 68  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 69  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 70  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 71  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 72  LAMEA MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 73  LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2012 – 2015, USD MILLION

TABLE 74  LAMEA MOLECULAR DIAGNOSTICS MARKET BY COUNTRY, 2016 – 2022, USD MILLION

TABLE 75  BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 76  BRAZIL MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 77  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 78  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 79  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 80  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 81  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 82  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 83  BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 84  BRAZIL INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 85  BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 86  BRAZIL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 87  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 88  BRAZIL MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 89  ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 90  ARGENTINA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 91  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 92  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 93  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 94  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 95  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 96  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 97  ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 98  ARGENTINA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 99  ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 100  ARGENTINA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 101  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 102  ARGENTINA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 103  UAE MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 104  UAE MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 105  UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 106  UAE MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 107  UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 108  UAE MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 109  UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 110  UAE MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 111  UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 112  UAE INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 113  UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 114  UAE ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 115  UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 116  UAE MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 117  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 118  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 119  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 120  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 121  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 122  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 123  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 124  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 125  SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 126  SAUDI ARABIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 127  SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 128  SAUDI ARABIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 129  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 130  SAUDI ARABIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 131  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 132  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 133  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 134  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 135  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 136  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 137  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 138  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 139  SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 140  SOUTH AFRICA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 141  SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 142  SOUTH AFRICA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 143  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 144  SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 145  NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 146  NIGERIA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 147  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 148  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 149  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 150  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 151  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 152  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 153  NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 154  NIGERIA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 155  NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 156  NIGERIA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 157  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 158  NIGERIA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 159  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2012 – 2015, USD MILLION

TABLE 160  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET, 2016 – 2022, USD MILLION

TABLE 161  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2012 – 2015, USD MILLION

TABLE 162  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY PRODUCT & SERVICES, 2016 – 2022, USD MILLION

TABLE 163  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2012 – 2015, USD MILLION

TABLE 164  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY TECHNOLOGY, 2016 – 2022, USD MILLION

TABLE 165  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2012 – 2015, USD MILLION

TABLE 166  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY APPLICATION 2016 – 2022, USD MILLION

TABLE 167  REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 168  REST OF LAMEA INFECTIOUS DISEASES MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 169  REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2012 – 2015, USD MILLION

TABLE 170  REST OF LAMEA ONCOLOGY MOLECULAR DIAGNOSTICS MARKET BY TYPE, 2016 – 2022, USD MILLION

TABLE 171  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2012 – 2015, USD MILLION

TABLE 172  REST OF LAMEA MOLECULAR DIAGNOSTICS MARKET BY END USER, 2016 – 2022, USD MILLION

TABLE 173  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 174  KEY INFORMATION – QUIAGEN N.V.

TABLE 175  KEY INFORMATION – ROCHE DIAGNOSTIC

TABLE 176  KEY INFORMATION – GRIFOLS

TABLE 177  KEY INFORMATION – SIEMENS HEALTHCARE (SIEMENS AG)

TABLE 178  KEY INFORMATION – BECTON DICKINSON AND COMPANY

TABLE 179  KEY INFORMATION – DANAHER CORPORATION


LICENSE TYPE